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Available online 6 April 2016Background: Bacillus thuringiensis Cry toxins bind with different insect midgut proteins leading to toxin
oligomerization, membrane insertion and pore formation. However, different Cry toxins had been shown to
readily form high molecular weight oligomers or aggregates in solution in the absence of receptor interaction.
The role of Cry oligomers formed in solution remains uncertain. The Cry9A proteins show high toxicity against
different Lepidoptera, and no-cross resistance with Cry1A.
Results: Cry9Aa655 protein formed oligomers easily in solution mediated by disulﬁde bonds, according to
SDS-PAGE analysis under non-reducing and reducing conditions. However, oligomerization is not observed if
Cry9Aa655 is activated with trypsin, suggesting that cysteine residues, C14 and C16, located in the N-terminal
end that is processed during activation participate in this oligomerization. To determine the role of these
residues on oligomerization and in toxicity single and double alanine substitution were constructed. In
contrast to single C14A and C16A mutants, the double C14A–C16A mutant did not form oligomers in solution.
Toxicity assays against Plutella xylostella showed that the C14A–C16A mutant had a similar insecticidal activity
as the Cry9Aa655 protein indicating the oligomers of Cry9Aa formed in solution in the absence of receptor
binding are not related with toxicity.
Conclusions: The aggregation of Cry9Aa655 polypeptides was mediated by disulﬁde bonds. Cry9Aa655 C14 and
C16C are involved in oligomerization in solution. These aggregate forms are not related to the mode of action
of Cry9Aa leading to toxicity.





Bacillus thuringiensis (Bt), a gram-positive bacterium, produces
insecticidal crystal proteins during its sporulation phase of growth [1].
These crystal proteins known as Cry toxins have been widely used
to control insect pests, including lepidoptera, diptera, and coleoptera
[2,3], mainly because they are non-toxic to non-target pests, and it is
safe to the environment [4,5,6].
The cry9Aa genes encoding a 130 kDa protein have been cloned
from several different B. thuringiensis strains [7,8]. Cry9-type proteins
show high toxic effect against several lepidoptera including Ostrinia
furnacalis, Plutella xylostella, Spodoptera exigua, Exorista larvarum,
Thaumetopoea pityocampa [9,10,11] and no-cross resistance with Cry1A
proteins [12]. An important additional information is that Cry9Aa
synergizes with Cry1Ca against Helicoverpa armigera, and Cry1Eaidad Católica de Valparaíso.
araíso. Production and hosting by Elagainst P. xylostella [13]. All these data indicate that Cry9Aa proteins
may be considered as good and wide prospects of commercial
application to control the Cry1A-resistance insects, and to reduce the
risk of insect resistance development by pyramiding them with other
cry genes. However, more information at the basic level still requires to
be done to evaluate the potential value of Cry9Aa proteins in the
biological control of insect pests.
In a previous work 12 truncated recombinants containing all three
domains of the Cry9Aa toxin were cloned in Escherichia coli, and we
found that the truncated recombinant Cry9Aa 1-655 (Cry9Aa655),
was the only one which was expressed as a primarily soluble form at
18°C, and showed insecticidal activity against P. xylostella similar to
the full-length Cry9Aa protein [14]. In this work we report that this
truncated protein is able to form oligomers in the solution.
Oligomerization of Cry1A toxins is triggered by receptor binding
promoving removal of helix alpha-1 [15,16]. Cry1Ab oligomers formed
after receptor binding have been shown to be involved in toxicity since
some single helix alpha-3 mutations severely affected oligomerization
and were not toxic to Manduca sexta [17]. However, different Crysevier B.V. All rights reserved.
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solution in the absence of receptor interaction. Güereca and Bravo [18]
reported that Cry1Aa, Cry1Ac, Cry1C, and Cry1D toxins are soluble and
forms monomers and high molecular mass aggregates of more than
ten monomers; Walters et al. [19] reported that alkaline-solubilized
Cry3A toxin formed a stable dimer in solution. Besides, Cry1Ie toxin
and Cry1Ah toxin can form oligomer in the solution that resulted in the
decrease of insecticidal activity compared with the monomer [20,21].
Although the oligomerization in solution of Cry9Aa655 did not
affect the toxicity against P. xylostella [14], the role of these oligomeric
forms on toxicity remains uncertain. In this manuscript we report
that Cry9Aa655 oligomerization depends on disulﬁde bonds,
according to the SDS-PAGE analysis of Cry9Aa655 polypeptides under
non-reducing and reducing conditions. Furthermore, mutational
analysis of cysteine residues C14 and C16 showed that a double
C14A–C16A mutant was affected in oligomer formation in solution.
Cry9Aa655 C14A–C16A mutant showed similar toxicity as Cry9Aa655
indicating that oligomers formed in solution are not related with
toxicity.
2. Materials and methods
2.1. Strains and Materials
The E. coli Rosetta (DE3) harboring the recombinant plasmid
pEB-cry9Aa655 was stored by the Institute of Plant Protection at the
Chinese Academy of Agricultural Sciences. The pEB vector (lac operator,
T7 promoter, multiple cloning site, His-Tag, HSV-Tag, lacZ start codon,
E. coli promoter, Ampr) is an expression vector in E. coli constructed by
our lab [22].
Ni-NTA agarose was purchased from General Electric Company. All
other chemical reagents were local products of analytical grade.
2.2. N terminal amino acids sequencing of cleavage activated Cry9Aa655
polypeptides by trypsin
The Cry9Aa655 polypeptides were digested by trypsin (Sigma) with
ratio of 1:10 (trypsin:protein,w/w) at 37°C for 3 h. The activated
polypeptides were puriﬁed by Superdex 75 (GE Healthcare) and
stored at 4°C. N-terminal amino acids sequencing was attempted
initially with this sample after being dissolved in water with limited
success. This sample was then run on SDS-PAGE gel and transferred
into PVDF membrane and sent to Huada Protein Research Center for
N-terminal sequencing.
2.3. Construction and expression of Cry9Aa655 mutants in E. coli
Single and double mutants of Cry9Aa655 (Table 1) were
constructed by Fast Mutagenesis System (TransGen Biotech)
using plasmid pEB-cry9Aa655 with His-tag after the cry9Aa655
gene as template. The preparation of Cry9Aa655 wild type and
mutant proteins were as follows. The cells were grown in 300 mL
of Luria–Bertani (LB) medium until the optical density of 0.5 at
600 nm, and the expression of the recombinants genes was
induced using isopropyl-β-D-thiogalactopyranoside (IPTG) at a
ﬁnal concentration of 0.5 mM. The cells were centrifuged after 10 h of
incubation with IPTG at 16°C. The cell pellet was resuspended in
20 mM Tris–HCl buffer (pH 8.0), sonicated (Ultrasonic processor,Table 1
Characterization of mutations of Cry9Aa655.
Mutations Characterization
Mutant C14A Single mutant: amino acid C14 on Cry9Aa was changed to alanine
Mutant C16A
Mutant C14A–C16A
Single mutant: amino acid C16 on Cry9Aa was changed to alanine
Double mutants: both C14 and C16 were changed to alanineNingbo Scientz Biotechnology Co., LTD) for 5 min (75% power), and
centrifuged at 23,000 ×g for 15 min at 4°C. The supernatants were
collected, and the pellet was resuspended in 20 mM Tris–HCl buffer
(pH 8.0). These samples were analyzed by SDS-PAGE (8%), and the
protein concentrations were determined using ImageJ software
(National Institutes of Health) with bovine serum albumin (BSA) as
standard.
2.4. Puriﬁcation of proteins
The supernatant of Cry9Aa655 wild type and mutations prepared as
described above was loaded onto a Ni-chelating sepharose column
previously equilibrated with binding buffer (20 mM Tris–HCl, 500 mM
NaCl, 50 mM imidazole, pH 8.0). The fraction that passed through was
collected and reloaded into the column to improve recovery of the
protein. The protein that bound to the column was eluted with elution
buffer 1 (20 mM Tris–HCl, 500 mM NaCl, 250 mM imidazole, pH 8.0),
followed by elution buffer 2 (20 mM Tris–HCl, 500 mM NaCl, 500 mM
imidazole, pH 8.0). The proteins collected were analyzed by SDS-PAGE.
2.5. The SDS-PAGE analysis of Cry9Aa655 polypeptides under non-reducing
and reducing conditions
The puriﬁed Cry9Aa655was dialyzed in different pH buffers (20mM
Na2CO3/NaHCO3 pH 9.0–11.5). Dialysis buffer was change for every 3 h.
After 12 h of dialysis, the samples were divided into two parts,
one sample was prepared under reducing condition (mixed with
loading buffer containing β-mercaptoethanol) while other samples
were prepared under non-reducing condition (mixed with loading
buffer without β-mercaptoethanol). Both samples were analyzed by
SDS-PAGE and gels stained using Coomassie Brilliant Blue R-250 stain
solution.
2.6. Bioassay
The insecticidal activities of the Cry9Aa655 mutations against
P. xylostella larvae were measured by fresh leaf disks using the leaf-dip
bioassay as described previously [23]. All mutant serial dilutions were
accurately prepared to ﬁnal concentrations of 0.03, 0.10, 0.30, 0.90,
and 2.70 μg/mL respectively with 20 mM Tris–HCl (pH 8.0) buffer, all
of the treatments were divided into three replicates in Petri dishes
(5 cm in diameter), and the products of pEB vector expressed in
Rosetta (DE3) strain were used as negative control. Thirty 2nd-instar
larvae were then placed onto each Petri dish with fresh leaf. The
numbers of surviving and dead larvae were recorded after 48 h. The
median lethal concentration (LC50) values were calculated using SPSS
Statistics 13.0 software.
3. Results
3.1. SDS-PAGE analysis of Cry9Aa655 dialyzed at different pHs
SDS-PAGE analysis of Cry9Aa655 under reducing (samples prepared
with β-mercaptoethanol, Fig. 1a) or non-reducing conditions (samples
prepared without β-mercaptoethanol, Fig. 1b) is shown in Fig. 1.
Under reducing condition, Cry9Aa655 at different pH's showed a
single band of approximately 66 kDa (Fig. 1a). However, under
non-reducing condition, besides the 66 kDa band (band 1), another
four bands of higher molecular weights were observed at the different
pH's analyzed (bands 2 to 5 in Fig. 1b). The formation of aggregates
with high molecular mass weight (N200 kDa, band 2 in Fig. 1b)
disappears at high pH (pH 11.0 to pH 11.5). These data suggest that
the formation of these Cry9Aa655-oligomers or -aggregates probably

































Fig. 1. SDS-PAGE analysis of Cry9Aa655 protein after dialysis in different pHbuffer (20mM
Na2CO3/NaHCO3 pH 9.0–11.5) for 12 h using reducing (with β-mercaptoethanol, (a)) and
non-reducing conditions (without β-mercaptoethanol, (b)), Q indicates sample before
dialysis. The numerals shown above each lane represent samples with different pH.
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Cry9Aa655 contains six cysteines: C14, C16, C39, C104, C241
and C413. To determine which cysteine residues are involved in
Cry9Aa655 oligomerization, Cry9Aa655 was activated for 3 h with
trypsin and the oligomerization of the trypsin activated Cry9Aa655 was
analyzed. Fig. 2 shows that the trypsin-activated protein was unable to
form oligomers in non-reducing conditions (lane 3) in contrast with
Cry9Aa655 that was not treated with trypsin (lane 4). Amino-terminal
end sequence of the trypsin activated protein was determined. The
results of N terminal sequencing of the activated Cry9Aa655 indicated
two possible N-terminal sequences 36NLNSCQNSSI45 (80% of sequence
obtained) 27ANNPYSSALNL37 (20% of sequence obtained) showing that
C14 and C16 are not present in the trypsin activated fragment.3.3. The SDS-PAGE analysis of oligomerization of mutations
To determine if C14 and C16 are involved in Cry9Aa655
oligomerization, single and double alanine substitutions in C14 and
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Fig. 2. SDS-PAGE analysis of oligomerization of truncatedCry9Aa655protein and activated
fragment. Trypsin-activated truncated Cry9Aa655 protein mixed with Laemmli
sample buffer with β-mercaptoethanol (lane 1) or without β-mercaptoethanol
(lane 3). Truncated Cry9Aa655 protein mixed with the Laemmli sample buffer with
β-mercaptoethanol (lane 2) or without β-mercaptoethanol (lane 4).the oligomerization was analyzed. Fig. 3 shows that single mutants on
either C14A or C16A still formed oligomers (Fig. 3, lane 2 and lane 3)
as Cry9Aa655. However, the double C14A–C16A mutant didn't form
oligomers, demonstrating that C14 and C16 are involved in
oligomerization of Cry9Aa655.
3.4. Toxicity of different cysteine mutants against P. xylostella
The LC50 values of the different mutants against P. xylostella larvae
are listed in Table 2. The Cry9Aa655 exhibited high toxicity against
P. xylostella (LC50 = 1.73 μg/mL, 1.04–4.15). All Cry9Aa655 mutants,
Cry9Aa655 C14A (LC50 = 1.33 μg/mL, 0.89–2.35), Cry9Aa655
C16A (LC50 = 1.41 μg/mL, 0.89–2.83) and Cry9Aa655 C14A–C16A
(LC50 = 2.26 μg/mL, 1.45–4.87) exhibited similar levels of insecticidal
activity as the Cry9Aa655. This bioassay result indicates that the
Cry9Aa655 oligomerization in solution is not involved in toxicity.
4. Discussion
The mechanism of action of Cry toxins is a multistep process, which
includes activating by trypsin-like gut proteases, binding to midgut
receptor(s), oligomerization and insertion into the membrane to form
lytic pores [24]. Oligomerization has been shown to be an important
step involved in this mechanism [16,17].
Some studies have found that oligomerization or aggregation of
different Cry toxins in solution decreases their insecticidal activity or
have no effect on toxicity. However the relevance of these oligomeric
forms formed in the absence of receptor binding remains uncertain.
To better understand whether oligomerization or aggregation of
Cry9Aa655 toxin in solution is important for toxicity, SDS-PAGE
analysis of Cry9Aa655 protein under reducing and non-reducing
conditions was conducted. Our data shows that the Cry9Aa655 toxin
produced high molecular mass bands when samples were prepared
without β-mercaptoethanol. However, oligomers were not observed
in samples prepared with β-mercaptoethanol. These results suggest
that the high molecular mass bands of Cry9Aa655 toxin observed in
SDS-PAGE under non-reducing conditions could be mediated by
disulﬁde bond formation. Disulﬁde bonds can be divided into two
kinds: Intra-molecular and Inter-molecular disulﬁde bonds [25]. The
disulﬁde bonds mentioned above may be the inter-molecular disulﬁde
bonds, which will be easy to break by β-mercaptoethanol at low
concentration compared to the intra-molecular disulﬁde bonds [26].
Most Cry toxins can be activated by trypsin proteases to produce
a mature toxin, leading to insect death [1]. The Cry9Aa655 protein
also can be digested by trypsin to form activated toxin with a size
of 60–65 kDa. After SDS-PAGE analysis of activated toxin under
non-reducing condition, we speculate that the fragment released by
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Fig. 3. SDS-PAGE analysis of oligomerization of truncated Cry9Aa655 protein andmutants.
Samples mixed with Laemmli sample buffer without β-mercaptoethanol (lanes 1–4) or
with β-mercaptoethanol (lanes 5–9). Mutant C14A–C16A (lanes 1, 5), Mutant C14A
(lanes 2, 6), Mutant C16A polypeptides (lanes 3, 7), Cry9Aa 655 polypeptides (lanes 4, 8).
Table 2
Bioassy results of mutants against P. xylostella larvae.
Treatment for insects LC50 (μg/mL) 95% conﬁdence interval
Cry9Aa655 1.73 1.04–4.15
Mutant C14A 1.33 0.89–2.35
Mutant C16A 1.41 0.89–2.83
Mutant C14A-C16A 2.26 1.45–4.87
Trypsin-activated fragment 2.80 2.25–3.84
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C14 and C16 were inferred to be involved in oligomerization of
Cry9Aa655 protein. The analysis of oligomerization of C14A and C16A
mutations demonstrated that both cysteine residues are involved in
oligomerization of Cry9Aa655 since a double Cry9Aa655 C14A–C16A
did not formed oligomers in solution.
Some studies have found that nonfunctional oligomerization
mediated by inter-molecular disulﬁde bond will affect the function of
the protein [27]. Fortunately, the oligomerization of Cry9Aa655
protein didn't affect the insecticidal activities according to the results
of bioassay against P. xylostella, unlike the oligomerization of activated
Cry1Ie and Cry1Ah [20,21]. The 3D structure of Cry9Aa predicted by
SWISS-MODLE workspace showed that the initiating amino acid on N
terminal end was residue 54, which indicated that although C14 and
C16 were involved in oligomerization, they were cut away during
activation with trypsin, and resulted in no affect to the toxicity against
P. xylostella. Our results indicate that Cry9Aa655 oligomers formed in
solution represent aggregates that are not related with toxicity.
5. Conclusions
The aggregation of Cry9Aa655 polypeptides was mediated
by disulﬁde bonds. Cry9Aa655 C14 and C16C are involved in
oligomerization in solution. These aggregate forms are not related
to the mode of action of Cry9Aa leading to toxicity.
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